EUVIMEDEUVIMED entdecken
Crossref

Characterisation of clinical, hematological and molecular variability in individuals with sickle β-thalassemia

Kalpita Gawit, Nagaraj Jaganathasamy, Vinod Umare, Sneha Dadheech, Pallavi Thaker, Nikhil Shinde, Aruna Jawade, Umesh Dhumane, Swati Dewalkar, Amol Moon, Naga Murlidhar Meregu, Sagar Bayaskar und 6 weitere

Blood Cells, Molecules, and Diseases · 2026

DOI: 10.1016/j.bcmd.2026.103035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026. Verfasst von Kalpita Gawit und 17 weiteren Autor:innen. Beteiligte Einrichtung: ICMR-Centre for Research, Management and Control of Hemoglobinopathies, Chandrapur, Maharashtra, India. Hauptthemen laut MEDLINE: beta-Thalassemia, Anemia, Sickle Cell. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sickle β-thalassemia (Sβ-thal) is a compound hemoglobinopathy resulting in marked clinical and hematologic heterogeneity. Despite a substantial disease burden in India, large-cohort data integrating molecular, hematologic, and clinical characteristics remain limited, particularly from regions with evolving screening programs. OBJECTIVES: The study aimed to characterise the clinical, hematological, and molecular features of a large cohort of individuals diagnosed with sickle β-thal. METHODS: A retrospective analysis of 206 molecularly confirmed Sβ-thal patients enrolled (2016 and 2024) at ICMR-CRMCH, Chandrapur. The demographic, clinical, and hematological parameters were analysed, including HPLC, along with molecular characterisation of β-globin mutations, α-globin gene deletions, and XmnI polymorphism using polymerase chain reaction-based methods. RESULTS: The mean age was 16.5 ± 13.2 years; 52.9% were female, and 77.7% were non-tribal. On molecular analysis, IVS I-5 (G > C) was the most common variant (98.0%), followed by Codon 15 (G > A) (1.5%) and Codon 8/9 (+G) (0.5%). The genotype αα/αα was predominant in the cohort (90.9%), and 86% were heterozygous for the Xmn1 polymorphism (+/-). HPLC longitudinal follow-up of children (newborn screening to 36 months) revealed that HbA2 (3.0-4.0%) stabilized after 18-24 months. In the clinical history of hospitalisation (58.5%), blood transfusions (51.8%), acute chest syndrome (27.4%), and splenomegaly (8.6%) were observed. CONCLUSION: These findings delineate the genotypic and phenotypic spectrum of Sβ-thal and underscore the need for cautious interpretation of HbA₂ in early childhood diagnosis and follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaAnemia, Sickle CellHumansFemaleMaleAdolescentChildRetrospective Studiesbeta-GlobinsMutationalpha-GlobinsYoung AdultGenotypeAdultChild, PreschoolIndiaPhenotype

Stichwörter der Autor:innen

HbA2Sickle cell diseaseSickle β-thalassemiaTribal and non-tribal

Substanzen

beta-Globinsalpha-Globins

Autor:innen und Institutionen

  • ICMR-Centre for Research, Management and Control of Hemoglobinopathies, Chandrapur, Maharashtra, India.
  • ICMR-National Institute of Immunohaematology (Recently renamed as National Institute for Research on Blood and Immune Disorders-NIRBID), Mumbai, Maharashtra, India.
  • Arihant Multispecialty Hospital, Nagpur, Maharashtra, 440026, India.
  • ICMR-Centre for Research, Management and Control of Hemoglobinopathies, Chandrapur, Maharashtra, India; ICMR-National Institute of Immunohaematology (Recently renamed as National Institute for Research on Blood and Immu…

Zitieren

APA

Gawit, K., Jaganathasamy, N., Umare, V., Dadheech, S., Thaker, P., Shinde, N., Jawade, A., Dhumane, U., Dewalkar, S., Moon, A., Meregu, N. M., Bayaskar, S., Khobragade, A., Jain, D., Nadkarni, A., Mukherjee, M., Kedar, P., & Madkaikar, M. (2026). Characterisation of clinical, hematological and molecular variability in individuals with sickle β-thalassemia. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2026.103035

Vancouver

Gawit K, Jaganathasamy N, Umare V, Dadheech S, Thaker P, Shinde N, et al. Characterisation of clinical, hematological and molecular variability in individuals with sickle β-thalassemia. Blood Cells, Molecules, and Diseases. 2026. doi:10.1016/j.bcmd.2026.103035

BibTeX
@article{Gawit2026,
  author = {Gawit, Kalpita and Jaganathasamy, Nagaraj and Umare, Vinod and Dadheech, Sneha and Thaker, Pallavi and Shinde, Nikhil and Jawade, Aruna and Dhumane, Umesh and Dewalkar, Swati and Moon, Amol and Meregu, Naga Murlidhar and Bayaskar, Sagar and Khobragade, Aniruddha and Jain, Dipty and Nadkarni, Anita and Mukherjee, Malay and Kedar, Prabhakar and Madkaikar, Manisha},
  title = {Characterisation of clinical, hematological and molecular variability in individuals with sickle β-thalassemia},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2026},
  doi = {10.1016/j.bcmd.2026.103035}
}
Kostenlos starten →